Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and Neck
Vitamin D (VitD) and its receptor (VDR) have been intensively investigated in many cancers. As knowledge for head and neck cancer (HNC) is limited, we investigated the (pre)clinical and therapeutic relevance of the VDR/VitD-axis. We found that VDR was differentially expressed in HNC tumors, correlat...
Main Authors: | Laura Koll, Désirée Gül, Manal I. Elnouaem, Hanaa Raslan, Omneya R. Ramadan, Shirley K. Knauer, Sebastian Strieth, Jan Hagemann, Roland H. Stauber, Aya Khamis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/5/4675 |
Similar Items
-
The Vitamin D Receptor–BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer
by: Aya Khamis, et al.
Published: (2022-10-01) -
Tuberculosis y vitamina D: una relación intrigante
by: C. F. Ramírez Ramos, et al.
Published: (2019-06-01) -
Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer
by: Désirée Gül, et al.
Published: (2022-05-01) -
Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020
by: Seyed Ghaderian, et al.
Published: (2022-12-01) -
Secondary Prevention of Diabetes Type 1 with Oral Calcitriol and Analogs, the PRECAL Study
by: Dimitrios T. Papadimitriou, et al.
Published: (2023-05-01)